UK yes hybrid embryo R&D
This article was originally published in Clinica
The UK's Human Fertilisation and Embryology Authority (HFEA) today announced the approval of two licences to conduct research using human-animal cytoplasmic hybrid embryos. Subject to a "series of detailed conditions in each case", Kings College London and Newcastle University will be able to perform the research for a period of one year. The applications were discussed at HFEA licence committee meetings on November 28 2007 and January 9 2008; minutes of the meetings are available from the HFEA (www.hfea.gov.uk).
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.